Mayer, Gert
University of Copenhagen · Steno Diabetes Center Copenhagen
3 papers on CoChatORCID 0000-0003-4605-1789
Most cited papers
- Verified
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
Heerspink, H. J. L., Perco, P., Mulder, S., Leierer, J., Hansen, M. K., Heinzel, A., & Mayer, G. (2019) · Diabetologia
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 457
- Verified
Association of the COVID-19 pandemic with internet search volumes: a Google Trends™ analysis
Effenberger, M., Kronbichler, A., Shin, J. I., Mayer, G., Tilg, H., & Perco, P. (2020) · International Journal of Infectious Diseases
Data-Driven Disease SurveillanceCOVID-19 epidemiological studies
Cited by 270
- Verified
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis
Agarwal, R., Tu, W., Farjat, A. E., Farag, Y. M. K., Toto, R., Kaul, S., Lawatscheck, R., Rohwedder, K., Ruilope, L. M., Rossing, P., et al. (2023) · Annals of Internal Medicine
Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension
Cited by 109
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free